BRPI1014081A2 - uso de uma bactéria da espécie bifidobacterium animalis subsp lactis cepa 420 (b420) ou uma mistura da mesma - Google Patents
uso de uma bactéria da espécie bifidobacterium animalis subsp lactis cepa 420 (b420) ou uma mistura da mesmaInfo
- Publication number
- BRPI1014081A2 BRPI1014081A2 BRPI1014081A BRPI1014081A BRPI1014081A2 BR PI1014081 A2 BRPI1014081 A2 BR PI1014081A2 BR PI1014081 A BRPI1014081 A BR PI1014081A BR PI1014081 A BRPI1014081 A BR PI1014081A BR PI1014081 A2 BRPI1014081 A2 BR PI1014081A2
- Authority
- BR
- Brazil
- Prior art keywords
- bacterium
- mixture
- bifidobacterium animalis
- lactis strain
- animalis subsp
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21856309P | 2009-06-19 | 2009-06-19 | |
| US61/218,563 | 2009-06-19 | ||
| PCT/IB2010/052757 WO2010146568A2 (en) | 2009-06-19 | 2010-06-18 | Bifidobacteria for treating diabetes and related conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI1014081A2 true BRPI1014081A2 (pt) | 2016-04-19 |
| BRPI1014081B1 BRPI1014081B1 (pt) | 2025-05-27 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| US20140348796A1 (en) | 2014-11-27 |
| WO2010146568A2 (en) | 2010-12-23 |
| WO2010146568A3 (en) | 2011-05-05 |
| ES2763137T3 (es) | 2020-05-27 |
| PL2808024T3 (pl) | 2019-09-30 |
| US20200316144A1 (en) | 2020-10-08 |
| US20230248786A1 (en) | 2023-08-10 |
| EP2442814B1 (en) | 2018-09-26 |
| EP2808024B1 (en) | 2019-04-24 |
| ES2729765T3 (es) | 2019-11-06 |
| US12594309B2 (en) | 2026-04-07 |
| CN104784694A (zh) | 2015-07-22 |
| CN104784220A (zh) | 2015-07-22 |
| PL2442814T3 (pl) | 2019-04-30 |
| US20210322491A1 (en) | 2021-10-21 |
| EP2442814A2 (en) | 2012-04-25 |
| CN102458415A (zh) | 2012-05-16 |
| DK3181134T3 (da) | 2020-01-20 |
| EP2808024A1 (en) | 2014-12-03 |
| US20190307815A1 (en) | 2019-10-10 |
| CN102458415B (zh) | 2015-05-20 |
| EP3181134A1 (en) | 2017-06-21 |
| EP3181134B1 (en) | 2019-10-30 |
| DK2442814T3 (en) | 2019-01-14 |
| CN104770739A (zh) | 2015-07-15 |
| US20250041358A1 (en) | 2025-02-06 |
| US20180021391A1 (en) | 2018-01-25 |
| DK2808024T3 (da) | 2019-06-11 |
| US20120107291A1 (en) | 2012-05-03 |
| PL3181134T3 (pl) | 2020-04-30 |
| CN104784219A (zh) | 2015-07-22 |
| ES2702977T3 (es) | 2019-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2318513T3 (da) | Ny probiotisk bifidobacterium longum | |
| LT3048165T (lt) | Naujasis bifidobacterium animalis subsp. lactis cect 8145 štamas ir jo panaudojimas viršsvorio ir nutukimo ir susijusių ligų gydymui ir (arba) prevencijai | |
| IL213039A (en) | Human anti-angiopoietin-2 antibodies, pharmacological compounds containing these antibodies, their nucleic acids encoded, and expression vectors | |
| ATE537707T1 (de) | Lactobacillus paracasei und gewichtskontrolle | |
| GB2460781B (en) | Probiotic bifidobacterium strains | |
| GB2465051B (en) | Probiotic bifidobacterium strains | |
| DK2657333T3 (da) | Porcint circovirus type 2, immunsammensætning indeholdende samme, assaykit og anvendelse deraf | |
| DE602006010723D1 (de) | Neues bakterium der gattung bifidobacterium und dessen nutzung | |
| PT2626076T (pt) | Utilizações terapêuticas de lactobacillus salivarus ls01 22775 | |
| DK1824500T3 (da) | Probiotisk lactobacillus-stamme til forbedret vaginal sundhed | |
| CL2012003026A1 (es) | Composicion farmaceutica que comprende pioglitazona y linagliptina; procedimiento de preparacion; uso en el tratamiento de la diabetes tipo 2 o la obesidad. | |
| BRPI1014304A2 (pt) | bifidobacterium longum ncc2705 (cncm i-2618) e distúrbios imunes | |
| DK1988163T3 (da) | Hla-a*3303-begrænset wt1 peptid og farmaceutisk sammensætning omfattende det samme | |
| BRPI0817905A2 (pt) | Utilização de uma cepa de bifidobacterium, para o preparo de uma composição destinada à prevenção e/ou ao tratamento de manifestações do tipo alérgicas | |
| MX389112B (es) | Uso de probioticos en el tratamiento y/o la prevencion de la enfermedad de la psoriasis. | |
| PL2176299T3 (pl) | Polisacharyd wyizolowany z Bifidobacterium infantis 35624 (NCIMB 41003) | |
| BR112015014693A2 (pt) | uso de bifidobacterium animalis para o tratamento ou a prevenção de ganho de peso corpóreo e resistência à insulina | |
| DK2802333T3 (da) | Lactobacillus rhamnosus og Bifidobacterium animalis subsp. lactis til anvendelse til forebyggelse eller behandling af øvre luftvejsinfektioner | |
| BRPI0807649A2 (pt) | Utilização de lactobacillus casei para reforçar a proteção induzida pela vacina antigripal | |
| BRPI1014081A2 (pt) | uso de uma bactéria da espécie bifidobacterium animalis subsp lactis cepa 420 (b420) ou uma mistura da mesma | |
| ATE421572T1 (de) | Neue stämme von lactobacillus helveticus | |
| ATE536102T1 (de) | Probiotischer stamm von lactobacillus delbrueckii subsp bulgaricus | |
| IL210068A0 (en) | Compositions and methods of use of orf 554 from beta hemolytic streptococcal strains | |
| ATE423840T1 (de) | Neue stämme von lactobacillus helveticus | |
| AP2409A (en) | Novel enterococcus and streptococcus strains and bacteriocins. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B25D | Requested change of name of applicant approved |
Owner name: DUPONT NUTRITION BIOSCIENCES APS (DK) |
|
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B25F | Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement |
Owner name: DUPONT NUTRITION BIOSCIENCES APS (DK) Free format text: A FIM DE ATENDER A ALTERACAO DE NOME REQUERIDA ATRAVES DA PETICAO NO 870240089625, DE 21/10/2024, E NECESSARIO APRESENTAR UMA GUIA DE RECOLHIMENTO, CODIGO 248, RELATIVA A ALTERACAO DE ENDERECO DA CEDENTE. ALEM DISSO, E PRECISO APRESENTAR A GUIA DE CUMPRIMENTO DE EXIGENCIA. |
|
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/06/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |
|
| B25E | Requested change of name of applicant rejected |
Owner name: DUPONT NUTRITION BIOSCIENCES APS (DK) Free format text: INDEFERIDO O PEDIDO DE ALTERACAO DE NOME CONTIDO NA PETICAO 870240089625 DE 21/10/2024, POR AUSENCIA DE CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI NO 2831, DE 08/04/2025. |
|
| B25D | Requested change of name of applicant approved |
Owner name: INTERNATIONAL NANDH DENMARK APS (DK) |
|
| B25G | Requested change of headquarter approved |
Owner name: INTERNATIONAL NANDH DENMARK APS (DK) |